Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ghersi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Health Information Management : Journal of the Health Information Management Association of Australia|February 7, 1996
Where's your proof? Evidence-based health care and the clinical data managerD Ghersi
The Cochrane Database of Systematic Reviews|June 14, 2003
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerN Wilcken, J Hornbuckle, D Ghersi
The Cochrane Database of Systematic Reviews|July 21, 2006
Addition of drug/s to a chemotherapy regimen for metastatic breast cancerD Jones, D Ghersi, N Wilcken
British Journal of Cancer|July 30, 2005
A systematic review of taxane-containing regimens for metastatic breast cancerD Ghersi, N Wilcken, R J Simes
The Cochrane Database of Systematic Reviews|April 24, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
The Medical Journal of Australia|November 10, 2001
Scientific background and rationale for a randomised controlled trialD Ghersi, V J Gebski, A C Keech, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
Lancet (London, England)|September 12, 1992
High versus low dose cisplatin in epithelial ovarian cancerD Ghersi, M K Parmar, D Guthrie, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Health Information Management : Journal of the Health Information Management Association of Australia|February 7, 1996
Where's your proof? Evidence-based health care and the clinical data managerD Ghersi
The Cochrane Database of Systematic Reviews|June 14, 2003
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerN Wilcken, J Hornbuckle, D Ghersi
The Cochrane Database of Systematic Reviews|July 21, 2006
Addition of drug/s to a chemotherapy regimen for metastatic breast cancerD Jones, D Ghersi, N Wilcken
British Journal of Cancer|July 30, 2005
A systematic review of taxane-containing regimens for metastatic breast cancerD Ghersi, N Wilcken, R J Simes
The Cochrane Database of Systematic Reviews|April 24, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
The Medical Journal of Australia|November 10, 2001
Scientific background and rationale for a randomised controlled trialD Ghersi, V J Gebski, A C Keech, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
Lancet (London, England)|September 12, 1992
High versus low dose cisplatin in epithelial ovarian cancerD Ghersi, M K Parmar, D Guthrie, et al.
Pageof 3